INOZYME PHARMA INC shareholders Q2 2023

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 74 filers reported holding INOZYME PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.65 and the average weighting 0.2%.

INOZYME PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 3,661,518$20,394,6556.72%
CHI Advisors LLC 1,195,027$6,656,3012.02%
Affinity Asset Advisors, LLC 751,796$4,187,5041.46%
Sofinnova Investments, Inc. 3,655,308$20,360,0661.33%
NEA Management Company, LLC 2,437,689$13,577,9281.04%
SPHERA FUNDS MANAGEMENT LTD. 1,131,967$6,305,0560.98%
Knott David M Jr 220,000$1,2250.49%
Rock Springs Capital Management LP 3,428,084$19,094,4280.45%
Deep Track Capital, LP 1,644,021$9,157,1970.42%
MPM BioImpact LLC 326,921$1,820,9500.37%
Overbrook Management Corp 219,326$1,221,6460.29%
EAM Investors, LLC 176,228$981,5900.18%
Parkman Healthcare Partners LLC 168,790$940,1600.16%
Total Clarity Wealth Management, Inc. 30,300$168,7710.08%
DENALI ADVISORS LLC 26,700$148,7190.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,250,000$23,672,5000.05%
Octagon Capital Advisors LP 49,702$276,8400.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 155,305$865,0490.03%
Woodline Partners LP 288,827$1,608,7660.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 116,600$649,4620.02%
External links

This page lists INOZYME PHARMA INC's shareholders in Q2 2023. To view INOZYME PHARMA INC's shareholder history, click here.